08/22/2026
I utilize this technology at ProMedica Total Rehab in Monroe, MI. We implemented a Breast Cancer Related Lymphedema Prevention program in 2022. The test is convenient, efficient with real time results, non-invasive, and FDA approved to monitor for Stage 0 lymphedema to prevent patients from developing stage 1 -3 lymphedema, which is irreversible at these later stages. By catching lymphedema at Stage 0 which means before symptoms, we have a greater chance at intervening and reducing or preventing lymphedema in patients who follow the protocol. 🌟 And now we will be able to also assess for Sarcopenia risk! This will help patients and their medical providers monitor their metabolic health during and after treatment. Because it does not use radiation, the test is safe for repeat testing as needed for close monitoring.
📣 If you are a clinician and don’t have access to this technology, please refer your patients that would benefit from this testing and help us in our efforts to improve survivorship outcomes.
SOZO® is now the only FDA-cleared BIS solution for sarcopenia risk assessment—flagging muscle loss early from a rapid routine scan in cancer care.